Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2000
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinomaN Tsavaris, D Skarlos, C Bacoyiannis, et al.Bone Marrow Transplantation|November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou, U Dafni, A Anagnostopoulos, et al.Cancer Chemotherapy and Pharmacology|September 29, 2007
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyE Briasoulis, G Fountzilas, A Bamias, et al.British Journal of Cancer|August 16, 2006
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerG P Stathopoulos, K Syrigos, G Aravantinos, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 29, 2019
Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patientsVasiliki Nikolaou, D Voudouri, G Tsironis, et al.Oncology|June 6, 2000
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experienceD Pectasides, T Economopoulos, G Kouvatseas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyG Aravantinos, G Fountzilas, P Kosmidis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyA Psyrri, K T Kalogeras, R Kronenwett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, C Papadimitriou, U Dafni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology GroupM A Dimopoulos, C Bakoyannis, V Georgoulias, et al.Pageof 9